Weilv Xu

Weilv Xu

Auto-generated profile, based on publicly available information

Weilv Xu

Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
WXWeilv Xu
Weilv Xu
QJQiao Jin
Qiao Jin
XLXinyue Li
Xinyue Li
DLDanyue Li
Danyue Li
XFXinyu Fu
Xinyu Fu
FSFushan Shi
Fushan Shi
Gasdermin D (GSDMD) functions as a pivotal executor of pyroptosis, eliciting cytokine secretion following cleavage by inflammatory caspases. However, the role of posttranslational modifications (PTMs) in GSDMD-mediated pyroptosis remains largely unexplored. In this study, we demonstrate that GSDMD can undergo acetylation at the Lysine 248 residue, and this acetylation enhances pyroptosis. We identify histone deacetylase 4 (HDAC4) as the specific deacetylase responsible for mediating GSDMD deacetylation, leading to the inhibition of pyroptosis both in vitro and in vivo. Deacetylation of GSDMD impairs its ubiquitination, resulting in the inhibition of pyroptosis. Intriguingly, phosphorylation of HDAC4 emerges as a critical regulatory mechanism promoting its ability to deacetylate GSDMD and suppress GSDMD-mediated pyroptosis. Additionally, we implicate Protein phosphatase 1 (PP1) catalytic subunits (PP1α and PP1γ) in the dephosphorylation of HDAC4, thereby nullifying its deacetylase activity on GSDMD. This study reveals a complex regulatory network involving HDAC4, PP1, and GSDMD. These findings provide valuable insights into the interplay among acetylation, ubiquitination, and phosphorylation in the regulation of pyroptosis, offering potential targets for further investigation in the field of inflammatory cell death.

6 February 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYanan Zhang
Yanan Zhang
STShuyu Tu
Shuyu Tu
XSXian Shao
Xian Shao
JMJinxin Meng
Jinxin Meng
ZZZhuobiao Zhang
Zhuobiao Zhang
SZShu Jeffrey Zhu
Shu Jeffrey Zhu
The gut microbiota sustains intestinal homeostasis, yet how microbial metabolites direct epithelial repair remains unclear. Here we identify indole-3-propionic acid (IPA), a tryptophan-derived bacterial metabolite, as a key regulator of mucosal healing. IPA activates PPARα in intestinal epithelial cells, enhancing transcription of the ketogenic enzyme HMGCS2 and boosting β‑hydroxybutyrate (BHB) production. BHB in turn stimulates LGR5⁺ intestinal stem cells, accelerating epithelial regeneration. Using germ-free models and the IPA‑producer Peptostreptococcus russellii, we show that dietary tryptophan and specific commensals sustain luminal IPA levels, which are critical for recovery in colitis. Restoration of IPA or BHB attenuates inflammation and barrier defects, outlining a microbiota‑metabolite‑stem cell axis that could be therapeutically targeted in inflammatory bowel disease and other barrier disorders.

25 February 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYanan Zhang
Yanan Zhang
JMJinxin Meng
Jinxin Meng
STShuyu Tu
Shuyu Tu
LMLinlin Ma
Linlin Ma
XZXinya Zhao
Xinya Zhao
SZShu Jeffrey Zhu
Shu Jeffrey Zhu
The gut microbiota plays a crucial role in maintaining intestinal stem cell (ISC) homeostasis and epithelial barrier integrity. Here, we report that Blautia coccoides (B. coccoides) is significantly reduced in inflammatory bowel disease (IBD) patients and dextran sulfate sodium (DSS)-induced colitis mice. Through an integrated approach combining RNA sequencing, metabolomic profiling, and ISC lineage tracing across multiple mucosal injury models, we demonstrate that B. coccoides colonization enhances β-hydroxybutyrate (BHB) production in intestinal epithelial cells (IECs), which activates HOPX⁺ reserve ISCs and promotes regeneration of the LGR5⁺ ISC pool, thereby accelerating epithelial repair. We further show that B. coccoides-derived indole-3-lactic acid (ILA), a tryptophan (Trp) metabolite, is converted into indole-3-propionic acid (IPA) by commensal bacteria such as P. russellii or C. sporogenes, stimulating IEC BHB synthesis. Using an engineered Escherichia coli strain expressing BC-derived phenyllactate dehydrogenase (fldH), we establish that both dietary Trp and bacterial fldH activity are essential for ILA/IPA generation and subsequent mucosal healing. Our findings reveal a microbiota-metabolite-ISC regulatory axis critical for epithelial regeneration and propose novel metabolite-based therapeutic strategies for IBD and other intestinal disorders associated with barrier dysfunction.

20 June 2025 in Advanced Science
Verified
Journal Article
Open access
WXWeilv Xu
Weilv Xu
SHSuhui He
Suhui He
WSWen Shi
Wen Shi
JXJinxia Xu
Jinxia Xu
SLShiyang Liu
Shiyang Liu
FSFushan Shi
Fushan Shi
The GSDMD N‐terminal fragment (GSDMD‐NT)‐mediated pyroptosis is extensively investigated. However, the role of the C‐terminal domain of GSDMD (GSDMD‐CT) is unexplored. This study demonstrates that GSDMD‐CT acts as a negative regulator that suppresses IFN‐I signaling during viral infection. Mechanistically, GSDMD‐CT, released upon virus infection, interacts separately with retinoic acid‐inducible gene I (RIG‐I) and tank‐binding kinase (TBK1), promoting the selective autophagic degradation of RIG‐I via K48‐linked polyubiquitination at Lys181 and TBK1 via K27‐linked polyubiquitination at Lys487 by the E3 ligase TRIM28, which serves as a recognition signal for the cargo receptor NDP52 and TOLLIP, respectively. Moreover, the P414, Q416, and E459 amino sites are crucial for GSDMD‐CT in counteracting antiviral responses. The findings highlight the role of GSDMD‐CT in inhibiting antiviral immunity, providing insights into how viruses manipulate host defense mechanisms to enhance infection.

2 October 2026 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
WXWeilv Xu
Weilv Xu
SLShiyang Liu
Shiyang Liu
ZYZexu Yu
Zexu Yu
JSJinhuang Shi
Jinhuang Shi
YYYang Yang
Yang Yang
FSFushan Shi
Fushan Shi
The gasdermin (GSDM) family of proteins has emerged as the central executioner of pyroptosis, a form of inflammatory cell death characterized by plasma membrane rupture and the release of pro-inflammatory cytokines such as interleukin-1β (IL-1β), IL-18 and high mobility group protein B1 (HMGB1). Emerging evidence indicates that GSDMs exert diverse functions in health and various disease contexts, which can be either dependent on or independent of pyroptosis, including facilitating mucus secretion, regulating bone resorption, and modulating mitochondrial metabolism. This review provides a comprehensive overview of the GSDM family, detailing the molecular mechanisms of activation, regulation, pore formation, cell rupture and membrane repair. We explored the extensive crosstalk between GSDMs and other cell death modalities, including apoptosis, necroptosis, NETosis, and PANoptosis. Furthermore, we systematically discuss GSDMs’ ‘double-edged sword’ roles in diverse pathologies, ranging from host defense in infectious diseases and chronic inflammation in autoimmune disorders to their complex, context-dependent function in cancer progression and immunity. Finally, we evaluate emerging therapeutic strategies, encompassing small-molecule inhibitors such as disulfiram (DSF), necrosulfonamide (NSA) and dimethyl fumarate (DMF), as well as novel material-based delivery systems. Collectively, these advances underscore the therapeutic potential of targeting GSDMs for precise clinical intervention to treat both inflammatory and non-inflammatory diseases, as well as to enhance cancer immunotherapy.